Values and DSM-5: looking at the debate on attenuated psychosis syndrome

BMC Medical Ethics
Arthur Maciel Nunes GonçalvesClaudio E M Banzato

Abstract

Although values have increasingly received attention in psychiatric literature over the last three decades, their role has been only partially acknowledged in psychiatric classification endeavors. The review process of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) received harsh criticism, and was even considered secretive by some authors. Also, it lacked an official discussion of values at play. In this perspective paper we briefly discuss the interplay of some values in the scientific and non-scientific debate around one of the most debated DSM-5 category proposals, the Attenuated Psychosis Syndrome (APS). Then, we point out some ethical consequences of a facts-plus-values perspective in psychiatric classification. Different stakeholders participated in the APS-debate and for analytical purposes we divided them into four groups: (i) researchers in the field of high-risk mental states; (ii) the DSM-5 Psychotic Disorders Work Group; (iii) patient, carers and advocacy groups; and (iv) external stakeholders, not related to the previous groups, but which also publicly expressed their opinions about APS inclusion in DSM-5. We found that each group differently stressed the role of values we e...Continue Reading

References

Jan 1, 1996·Schizophrenia Bulletin·T H McGlashan, J O Johannessen
Mar 21, 1998·The Journal of Medicine and Philosophy·J Z Sadler
Apr 30, 1998·European Archives of Psychiatry and Clinical Neuroscience·P D McGorry
Jun 28, 2005·Journal of the History of the Behavioral Sciences·Rick Mayes, Allan V Horwitz
Feb 28, 2006·The American Journal of Bioethics : AJOB·Edmund D Pellegrino
Aug 25, 2007·Annual Review of Clinical Psychology·Steven E Hyman
Apr 13, 2010·Schizophrenia Research·Cheryl M CorcoranBarbara Cornblatt
Apr 13, 2010·Schizophrenia Research·Alison R YungStephen J Wood
Jan 5, 2011·Psychiatry·Darrel A RegierJames P McNulty
May 4, 2011·The American Journal of Psychiatry·William T Carpenter, Jim van Os
Feb 9, 2012·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Alison R Yung, Barnaby Nelson
Nov 13, 2012·Schizophrenia Bulletin·Alison R YungThomas H McGlashan
Nov 21, 2012·JAMA Psychiatry·Paolo Fusar-PoliAlison Yung
Feb 2, 2013·Current Opinion in Psychiatry·James Phillips
Jun 19, 2013·Schizophrenia Research·Ming T TsuangWilliam Carpenter
Sep 3, 2013·The Journal of Nervous and Mental Disease·Michael B First
Jan 30, 2014·Annual Review of Clinical Psychology·P Fusar-PoliT H McGlashan
Jul 12, 2014·Psychopathology·Barnaby Nelson
Jul 26, 2014·Psychopathology·William T Carpenter
Feb 14, 2015·Epidemiology and Psychiatric Sciences·J C Wakefield

❮ Previous
Next ❯

Citations

May 16, 2017·The International Journal of Social Psychiatry·K S Jacob
Oct 28, 2020·International Journal of Environmental Research and Public Health·Ke Tien Yen, Shen Cherng

❮ Previous
Next ❯

Software Mentioned

APA

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.